Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03523689 · ClinicalTrials.gov registry record

Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
57
Enrollment target

NCT03523689: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT03523689 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03523689 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
57 participants
Enrollment target

Study Summary

This trial studies how well radial-probe endobronchial ultrasound works in detecting the complete or partial collapse of the lung in patients undergoing peripheral bronchoscopy. Diagnostic procedures, such as radial-probe endobronchial ultrasound and bronchoscopy, use a thin, tube-like instrument inserted through the nose or mouth to view and take pictures of the inside of the trachea, air passages, and lungs.

Primary Outcome

Presence or absence of atelectasis within each of the aforementioned 8 segments will be determined using radial-probe endobronchial ultrasound (RP-EBUS) in comparison with the most recent computed tomography (CT) performed \< 4 weeks prior to the bronchoscopy. A segment will be identified as having a new atelectasis if there is an indication of solid- or semisolid-appearing lesion by RP-EBUS without a corresponding indication of solid tumor or atelectasis on the preoperative CT. Descriptive stat

Interventions

  • PROCEDURE Bronchoscopy
  • PROCEDURE Radial Probe Endobronchial Ultrasound

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2018-04-30
Est. Completion 2020-10-26
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT03523689 record still lists

NCT03523689 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Bronchoscopy is the first listed.

NCT03523689 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03523689 about?

NCT03523689 is a clinical study titled "Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy". This trial studies how well radial-probe endobronchial ultrasound works in detecting the complete or partial collapse of the lung in patients undergoing peripheral bronchoscopy. Diagnostic procedures, such as radial-probe endobronchial ultrasound and bronchoscopy, use a thin, tube-like instrument in...

What is the current status of trial NCT03523689?

This trial is currently completed. The enrollment target is 57 participants. The study started on 2018-04-30. Estimated completion is 2020-10-26.

What interventions are being tested in trial NCT03523689?

The interventions under investigation include: Bronchoscopy (PROCEDURE), Radial Probe Endobronchial Ultrasound (PROCEDURE).

Who is sponsoring clinical trial NCT03523689?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03523689, the US trial registry maintained by the National Library of Medicine. NCT03523689 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.